Marker Therapeutics Inc (MRKR)

Marker Therapeutics Inc (MRKR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $17.3M; returns 1 day -10.3%, 1 week -7.7%, 1 year -3.5%.

Marker Therapeutics is a clinical-stage immuno-oncology company specializing in a proprietary "Multi-Antigen Recognizing" (MAR-T) cell therapy platform.

Groups MRKR belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Clinical Stage
• Cancer Therapeutics
• Healthcare
• Life Sciences
• Biopharmaceutical

MRKR financial model: income statement, cash flow and balance sheet